CLINICAL_TRIALS
trial_result
· 2009-05-11
Clinical Trial Update: TRF-1101 Assessment in Sickle Cell Disease [Phase 1, Phase 2]
Summary
The Phase 1/2 trial TRF-1101 for sickle cell disease has been terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: TRF Pharma, Inc | Conditions: Sickle Cell Disease | Phase 1, Phase 2 | Status: TERMINATED